Shaily Engineering Plastics Limited has released the transcript for its Q1 FY27 earnings conference call, held on August 10, 2026. The call detailed the company’s operational performance and strategic initiatives, highlighting strong growth in the Healthcare segment, new product development, and expansion plans across its Consumer Electronics and Semiconductor Trays businesses. Management expressed confidence in meeting future targets and growth projections.
Q1 FY27 Earnings Call Transcript Released
Shaily Engineering Plastics Limited has officially published the transcript for its Q1 FY27 earnings conference call, which took place on August 10, 2026. This document provides a comprehensive overview of the company’s performance during the quarter ended June 30, 2026, and its outlook for the upcoming periods.
Key Financial and Operational Highlights
During the call, management detailed the company’s financial results, including a 14% year-on-year growth in consolidated revenue for Q1 FY27, reaching INR281 crores. EBITDA saw an 18% increase to INR83 crores, with an improved margin of 29.7%. Profit after tax grew by 17% to INR48 crores, with a PAT margin of 17.1%.
Segment Performance Insights
The Healthcare segment demonstrated robust performance, with revenue increasing by 85% year-on-year to INR142 crores, contributing 51% of the total business. The Industrial revenue grew by 25% to INR23 crores. Conversely, Consumer revenue experienced a 24% decline to INR116 crores, attributed to softer demand in Europe and the US. Management also discussed progress in the Consumer Electronics and Semiconductor Trays segments, with planned investments and new customer acquisitions.
Strategic Growth Initiatives
Shaily Engineering Plastics is actively pursuing strategic growth initiatives. The company is focusing on expanding its presence in healthcare with new auto-injector platforms, including emergency use, reusable, and on-body injectors, with several expected to launch by the end of the year or in the near future. Investments are also planned for the Consumer Electronics and Semiconductor Trays businesses, aiming to scale up operations and capture market opportunities.
Future Outlook
Management expressed optimism regarding the company’s future performance, citing a diversified business model, expanding healthcare platforms, and disciplined execution. Confidence was reiterated in achieving future targets, including a full-year guidance of 36 million devices, with expectations to potentially exceed this number. The company anticipates continued momentum in its Healthcare business and domestic focus in Semiconductor and Consumer Electronics.
Source: BSE
